OpenVSafe by OpenVAERS
Search V-safe

D2V-32939-49987

4 vaccinations 3 coded responses 17 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
200 / DC
Registered
2021-03-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-08
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-21
    Registered in v-safe
  3. 2021-03-21
    Health check-in — 7 day, dose 1
    Feeling: Good · Headache
    Adult check-in
  4. 2021-03-22
    Health check-in — 14 day, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-03-29
    Health check-in — 21 day, dose 1
    Feeling: Good
    Adult check-in
  6. 2021-03-30
    Dose 2 — Pfizer-BioNTech
  7. 2021-04-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-04-06
    Health check-in — 7 day, dose 2
    Feeling: Good · Headache
    Adult check-in
  9. 2021-04-13
    Health check-in — 14 day, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-04-13
    Pregnancy registry survey
    Pregnant at time of vaccination · Yes, I would like someone to contact me
  11. 2021-04-22
    Health check-in — 21 day, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-27
    Health check-in — 28 day, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-04
    Health check-in — 35 day, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-05-11
    Health check-in — 42 day, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-06-29
    Health check-in — 3 month, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-09-28
    Health check-in — 6 month, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-11-16
    Dose 3 — Pfizer-BioNTech
  18. 2022-03-30
    Survey response — 12 month, dose 2
    MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: Good
    MedDRA releases: 2024-11 · check-in answers available
  19. 2022-09-12
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  20. 2022-10-05
    Survey response — 21 day, dose 4
    MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11 · check-in answers available
  21. 2022-10-05
    Report sent to call center — 21 day, dose 4
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  22. 2022-10-06
  23. 2022-10-17
    Health check-in — 35 day, dose 4
    Feeling: Good
    Adult check-in
  24. 2022-12-12
    Health check-in — 3 month, dose 4
    Feeling: Good
    Adult check-in
  25. 2023-03-13
    Survey response — 6 month, dose 4
    MedDRA: Deafness, Ear infection, Eustachian tube dysfunction, Nasopharyngitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11 · check-in answers available
  26. 2023-03-13
    Report sent to call center — 6 month, dose 4
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  27. 2023-03-14
  28. 2023-03-14

Vaccinations

DoseDateManufacturerCo-administered
12021-03-08Pfizer-BioNTech
22021-03-30Pfizer-BioNTech
32021-11-16Pfizer-BioNTech No
42022-09-12Pfizer-BioNTech Flu

Call center

ReportedOutcomeVAERS-related outcome
2022-10-05 Unsuccessful
2023-03-13 Unsuccessful

Free text

Release 11

Symptoms: Congestion, general cold symptoms

Release 12

Symptoms: Cough, congestion

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDDeafness · · ✓
SDEar infection · · ✓
SDEustachian tube dysfunction · · ✓
SDNasopharyngitis · · ✓
SDRespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release